194 related articles for article (PubMed ID: 22002537)
1. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
[TBL] [Abstract][Full Text] [Related]
2. [A new player in PML-mediated cellular senescence: TBX2 gets into the loop].
Martin N; Dejean A; Bischof O
Med Sci (Paris); 2012 Mar; 28(3):248-50. PubMed ID: 22480643
[No Abstract] [Full Text] [Related]
3. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence.
Talluri S; Dick FA
Cell Cycle; 2014; 13(4):641-51. PubMed ID: 24351540
[TBL] [Abstract][Full Text] [Related]
5. Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
Scaglioni PP; Rabellino A; Yung TM; Bernardi R; Choi S; Konstantinidou G; Nardella C; Cheng K; Pandolfi PP
EMBO Mol Med; 2012 Jul; 4(7):594-602. PubMed ID: 22359342
[TBL] [Abstract][Full Text] [Related]
6. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
7. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
8. UV-mediated regulation of the anti-senescence factor Tbx2.
Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
[TBL] [Abstract][Full Text] [Related]
9. Regulation of E2Fs and senescence by PML nuclear bodies.
Vernier M; Bourdeau V; Gaumont-Leclerc MF; Moiseeva O; Bégin V; Saad F; Mes-Masson AM; Ferbeyre G
Genes Dev; 2011 Jan; 25(1):41-50. PubMed ID: 21205865
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
Fang W; Mori T; Cobrinik D
Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
[TBL] [Abstract][Full Text] [Related]
11. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
12. PML promotes senescence via JAK/STAT signaling.
Krämer A
Cell Cycle; 2010 Aug; 9(15):2931. PubMed ID: 20703079
[No Abstract] [Full Text] [Related]
13. PML is a direct p53 target that modulates p53 effector functions.
de Stanchina E; Querido E; Narita M; Davuluri RV; Pandolfi PP; Ferbeyre G; Lowe SW
Mol Cell; 2004 Feb; 13(4):523-35. PubMed ID: 14992722
[TBL] [Abstract][Full Text] [Related]
14. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
[TBL] [Abstract][Full Text] [Related]
15. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.
Bourdeau V; Baudry D; Ferbeyre G
Front Biosci (Landmark Ed); 2009 Jan; 14(2):475-85. PubMed ID: 19273079
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.
Münch S; Weidtkamp-Peters S; Klement K; Grigaravicius P; Monajembashi S; Salomoni P; Pandolfi PP; Weißhart K; Hemmerich P
Mol Cell Biol; 2014 May; 34(10):1733-46. PubMed ID: 24615016
[TBL] [Abstract][Full Text] [Related]
18. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
19. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
20. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]